Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

BACKGROUND: Breast cancer is a complex disease with a highly immunosuppressive tumor microenvironment, and has limited clinical response to immune checkpoint blockade (ICB) therapy. T-helper 2 (Th2) cells, an important component of the tumor microenvironment (TME), play an essential role in regulati...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuru, Sun, Jiazheng, Luo, Yachan, Liu, Jiazhou, Wang, Xiaoyu, Feng, Rui, Huang, Jing, Du, Huimin, Li, Qin, Tan, Jinxiang, Ren, Guosheng, Wang, Xiaoyi, Li, Hongzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783715/
https://www.ncbi.nlm.nih.gov/pubmed/36564797
http://dx.doi.org/10.1186/s12967-022-03807-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783715/
https://www.ncbi.nlm.nih.gov/pubmed/36564797
http://dx.doi.org/10.1186/s12967-022-03807-8

Ejemplares similares